Search for: "US Department of Health and Human Service"
Results 1021 - 1040
of 10,579
Sorted by Relevance
|
Sort by Date
12 Oct 2022, 10:00 pm
On October 3, the Office of Inspector General (OIG) of the US Department of Health and Human Services issued a report titled “UPICs Hold Promise to Enhance Program Integrity Across Medicare and Medicaid, But Challenges Remain. [read post]
25 Oct 2023, 10:00 pm
The US Department of Health and Human Services Office of Inspector General (OIG) recently released Advisory Opinion No. 23-07, in which OIG approved a proposed arrangement to pay employed physicians bonuses based on net profits derived from certain ambulatory surgery center procedures performed by the physicians. [read post]
22 Apr 2021, 10:00 pm
In a not-so-unexpected turn of events, the Biden-Harris administration’s Department of Health and Human Services (HHS) and the US Food and Drug Administration (FDA) rescinded a notice issued by the Trump administration’s HHS days before leaving office exempting seven glove types from 510(k) premarket notification and proposing to do the same for 84 other devices ranging from gowns to ventilators. [read post]
25 Oct 2023, 10:00 pm
The US Department of Health and Human Services Office of Inspector General (OIG) recently released Advisory Opinion No. 23-07, in which OIG approved a proposed arrangement to pay employed physicians bonuses based on net profits derived from certain ambulatory surgery center procedures performed by the physicians. [read post]
1 Apr 2013, 11:00 pm
On March 26, the US Department of Health and Human Services Office of Inspector General (OIG) issued a Special Fraud Alert on physician-owned entities, specifically physician-owned distributorships (PODs). [read post]
25 Oct 2020, 10:00 pm
The US Department of Health and Human Services (HHS) issued two welcome announcements on October 22 relating to the CARES Act Relief Fund Provider Relief Fund (PRF). [read post]
23 May 2016, 1:25 pm
The 2016 poverty income guideline amount for a single person as reported by the United States Department of Health and Human Services is $11,880 and the 2016 self-support reserve is $16,038. [read post]
28 Nov 2019, 2:25 am
An alert has been issued by the US Department of Health and Human Services Office of Inspector General about a fraud scheme that involves genetic testing. [read post]
19 Apr 2021, 10:00 pm
Given the significant push to vaccinate the public since the start of 2021, the increasing availability of vaccines, and the need to recruit additional personnel to administer vaccinations, the secretary of the US Department of Health and Human Services (HHS) has again amended its declaration under the Public Readiness and Emergency Preparedness Act (PREP Act) to accommodate some workforce barriers that had not been previously contemplated. [read post]
14 Sep 2020, 10:00 pm
Our FDA team recently posted a LawFlash about the US Department of Health and Human Services (HHS) August 19 announcement, Rescission of Guidances and Other Informal Issuances Concerning Premarket Review of Laboratory Developed Tests, in which it stated that the FDA would not require premarket review of laboratory developed tests (LDTs) without notice-and-comment rulemaking. [read post]
16 Apr 2010, 9:06 am
[JURIST] US President Barack Obama on Thursday ordered Department of Health and Human Services (HHS) [official website] Secretary Kathleen Sebelius [official profile] to expand the rights [memo] of patients and non-related visitors in hospitals that receive funding from Medicaid and Medicare [official websites]. [read post]
25 Oct 2023, 10:00 pm
The US Department of Health and Human Services Office of Inspector General (OIG) recently released Advisory Opinion No. 23-07, in which OIG approved a proposed arrangement to pay employed physicians bonuses based on net profits derived from certain ambulatory surgery center procedures performed by the physicians. [read post]
14 Sep 2020, 10:00 pm
Our FDA team recently posted a LawFlash about the US Department of Health and Human Services (HHS) August 19 announcement, Rescission of Guidances and Other Informal Issuances Concerning Premarket Review of Laboratory Developed Tests, in which it stated that the FDA would not require premarket review of laboratory developed tests (LDTs) without notice-and-comment rulemaking. [read post]
17 Jan 2024, 10:00 pm
The US Department of Health and Human Services Office of Inspector General (OIG) published favorable Advisory Opinion No. 23-15 on January 3, which concluded that a consultant’s proposal to provide gift cards to existing physician practice customers in exchange for referring other physician practices to the vendor would not implicate the federal Anti-Kickback Statute (AKS). [read post]
12 Oct 2022, 10:00 pm
On October 3, the Office of Inspector General (OIG) of the US Department of Health and Human Services issued a report titled “UPICs Hold Promise to Enhance Program Integrity Across Medicare and Medicaid, But Challenges Remain. [read post]
12 Oct 2022, 10:00 pm
On October 3, the Office of Inspector General (OIG) of the US Department of Health and Human Services issued a report titled “UPICs Hold Promise to Enhance Program Integrity Across Medicare and Medicaid, But Challenges Remain. [read post]
25 Oct 2020, 10:00 pm
The US Department of Health and Human Services (HHS) issued two welcome announcements on October 22 relating to the CARES Act Relief Fund Provider Relief Fund (PRF). [read post]
1 Feb 2022, 12:24 pm
According to the Department of Health and Human Services (HHS), there were 48 million uninsured in 2010 when the Affordable Care Act (ACA) became law. [read post]
2 Sep 2019, 9:00 pm
The proposed rule seeks to align the NRC’s drug testing requirements in Part 26 with the US Department of Health and Human Services’ (HHS’s) 2008 Mandatory Guidelines for Federal Workplace Drug Testing Programs (the 2008 Guidelines). [read post]
14 Sep 2020, 10:00 pm
Our FDA team recently posted a LawFlash about the US Department of Health and Human Services (HHS) August 19 announcement, Rescission of Guidances and Other Informal Issuances Concerning Premarket Review of Laboratory Developed Tests, in which it stated that the FDA would not require premarket review of laboratory developed tests (LDTs) without notice-and-comment rulemaking. [read post]
